Antidepressants and sexual
stimulation: the correlation
by
Chebili S, Abaoub A, Mezouane B, Le Goff JF
Psychiatre des Hopitaux,
EPS Ville Evrard,
Neuilly-sur-Marne.
Encephale 1998 May-Jun; 24(3):180-4

ABSTRACT

The purpose of this study is to correlate antidepressant treatment with sexual stimulation. The first part of this paper tries to describe some physiologic aspects of the sexual function. This complex subject includes several neuromediators which belong to adrenergic, cholinergic, dopaminergic and serotoninergic systems. A double-blind study shows that viloxazine, an atypical antidepressant, could act specifically on sex drive by desinhibiting effect. A precise study concludes that moclobemide improve significantly all components of sexual function. The numerous side effects of doxepine is a hindrance to its prescription. More precise studies about viloxazine and moclobemide suggest that both could have a specific effect on different components of sexual activity. In the second part of this paper, we consider the concept of "corrector". These drugs are numerous, however their prescriptions are not very wide spread: yohimbine, cyproheptadine, amantadine, bethanechol.

SSRIs
Viagra
Serotonin
Bupropion
Viloxazine
Fluoxetine
Yohimbine
Amineptine
Nitric oxide
Amantadine
Moclobemide
Phentolamine
Androgens in women
Designer Aphrodisiacs
Antidepressants and sex
Antidepressants and ejaculation
Sexual heath: sildenafil (Viagra)

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family